隆重推出全新平台

logoAsset-2

最新功能：现在您可以上传外部文件，将其与GLG研究项目合并，体验我们最新的综合分析功能，
或者点击“询问AI”以使用对话功能深入探索您的研究内容。了解更多信息。

立即登录

深度挖掘专家电话访谈的价值

结合几十年的经验与强大的技术支持，我们让您能更轻松地找到合适的专家、安排访谈，整理研究内容，并在日益复杂的世界中提取最重要的洞察。

项目主页

    • 借助统一视图，一站式管理所有待办事项，例如查看新增专家的相关信息、安排访谈时间
    • 选定研究重点，以跟踪进度并利用相关信息辅助后续决策，或查看所有项目研究角度的简要总结。

    • 查看近期访谈安排，预先准备，把握重点

我的专家

  • 直接搜索我们的专家网络

  • 通过筛选器以查看符合您标准的专家

  • 将专家档案添加到您的项目以表示您的兴趣

我的内容

  • 针对通话记录运行个性化的综合分析

  • 基于内容摘要、主题归纳和直接引述提取关键洞见

  • 识别不同观点之间的关联和差异

  • 通过添加、删除或修改主题，实时更新摘要

我的内容

  • 针对通话纪要和上传的文件内容，运行个性化综合分析

  • 基于内容摘要、主题归纳和直接引述提取关键洞见

  • 识别不同观点之间的关联和差异

  • 通过添加、删除或修改主题，实时更新摘要

  • 使用‘询问AI’功能，定位市场趋势，提炼特定细节，并轻松分析您的综合数据，同时提供完整的引用段落

您是否尝试过综合分析功能？

点击一次即可分析您所有的纪要

AI驱动的综合分析将帮助您快速提取多个通话纪要的关键洞察，包括上传的文件内容，从而加速您的研究。

表格视图和卡片视图：查看综合分析提取的结果，包括执行摘要、按主题分类的洞察总结及与每个主题相关的专家观点

询问AI：一个先进的对话功能，可定位市场趋势、提炼特定细节，并轻松分析您的综合数据，同时提供完整的参考洞见。

上传第三方内容：将外部文件与您的GLG研究合并，在GLG安全的平台内获取涵盖所有研究内容的全面理解。

"我对myGLG的综合分析功能印象深刻。这让我的团队比以往更快地完成工作。myGLG的功能比其他平台更强大，显然这个功能让GLG向正确的方向发展。"
高级总监 定量分析与数据科学
"myGLG的综合分析功能是一个真正的差异化功能，也是我未来选择与GLG合作的原因。其他服务平台提供商都没有类似功能。"
顾问医疗决策分析
"myGLG的综合分析功能是其他平台功能的更优版本。我们刚获得了访问会议纪要的权限，并且能够在几分钟内综合分析10篇专家通话纪要，这极其有用。"
投资者 私募股权
"我真的很喜欢综合分析的对话功能。我特别欣赏带有时间戳的内容引用来源，这可以让我能回到录音的具体位置。对话功能让挖掘可用于报告的材料变得更简单。"
经理 聚合物市场开发
"综合分析功能是GLG打造的护城河，因此我一直没有使用其他竞争对手的服务，正是因为有了这个功能，也让我远离其他专家网络平台。"
高级战略顾问

常见问题解答

如需了解更多信息，请联系您的客户经理，或者查看以下常见问题解答。

是否可以立即开始使用新功能？

是的！* 在此处登录， 探索全新的 myGLG 平台。有两种方式供您选择：

  1. 在“我的项目”下点击进入进行中的项目或过往项目，或者
  2. 从主页开始一个新项目。

您过去三年内的所有过往及进行中的项目均可在新版 myGLG 中查看。

*具体功能的访问权限取决于贵公司的设置。

  • 登录 myGLG.
  • 点击 “+ 新项目” 右上角的
  • 输入项目的基本信息即可开始体验

如果您通过搜索功能找到了想联系的专家，您可以直接通过平台发出与该专家通话的请求。根据是否需要从该专家处收集更多信息、确认专家的可预约时间段等，我们将采取一切必要步骤来促成这次通话。所有的专家匹配，无论您是通过平台搜索，还是通过GLG服务团队推荐，在和您进行直接通话之前，都会经过我们行业领先的合规审查。

并非所有专家都会出现在搜索结果中——我们的系统会优先显示最有可能快速响应的专家。不过，您的GLG服务团队将继续：

  • 在已显示的搜索结果之外进行搜索，以及
  • 推荐其他专家，包括为您的项目定制招募的专家。
 

随时都可以。欢迎联系您的客户团队，他们将为您展示未来启动项目时可实现的所有功能。

  • 您可以通过 9 种主要语言（英语、西班牙语、德语、法语、意大利语、葡萄牙语、日语、韩语和简体中文）体验 myGLG 平台，项目主页也支持多语言切换。
  • 专家搜索功能和搜索结果目前以英文显示。
  • 通话记录支持 40 余种语言，摘要语言将与通话语言保持一致。

您可直接与同事就任何共享项目展开协作，涵盖“我的专家”动态、已预约通话或完整通话记录等。您还可通过“项目主页”管理该项目下的团队成员名单。

是的！价格不会变动，所有新功能都包含在内，无需额外费用。

您的研究洞见始终归您所有。GLG 不会存储或使用相关数据来训练大型语言模型 (LLM)。我们承诺仅采用在隐私保护、数据安全和 AI 伦理方面具备严格政策且享有良好声誉的 AI 模型。

这些功能严格限定仅从通话纪要中提取内容，且全程遵循贵公司和 GLG 的合规要求进行设置和执行。如果需要，我们将与您一起更新您的设置以满足您的要求。

当然。我们非常高兴推出这些新功能，并期待尽快为您打造更高效的决策工具，涵盖专家访谈及更多应用场景。

立即登录
立即登录

Speaker Biographies

Hilary Malone PhD, has over 25 years of experience in global drug development, regulatory &government affairs, manufacturing and commercialization within the biopharma industry. Hilary hassignificant board level and executive committee experience including large scale organizationalrestructuring/transformation/integration, major M&A, biotech start-up, capital raising, investorrelations and pre-IPO.​

Hilary is currently CEO of Stylus Medicine, a private genetic medicine biotech company. Previously sheserved as CEO of a Series-A neuroscience company. Prior to these roles, Hilary served as COO & EVP atValo Health Inc., Chief Regulatory Officer & SVP at Sanofi Inc., and Chief Regulatory Officer & SVP atPfizer and Wyeth. Previous experience also includes senior regulatory and drug development roles atReata Pharmaceuticals Inc., AstraZeneca plc and GlaxoSmithKline plc.​

Hilary also serves on the Board of Directors of Hansa Biopharma and Adthera Bio. Hilary holds a PhD inMolecular Neuropharmacology and a BSc in Physiology.

Dr. Thomas Lönngren is Director at his own company PharmaExec Consulting AB. He is the Chairman of the Board of directors at Egetis Therapeutics AB, Sweden. Dr Lönngren also serves as board member at Compass Pathways PLC, London UK and NDA Group, Sweden. He acts as advisor to the following companies and organizations: NDA group, Sweden, Sweden, Artis Venture, San Francisco, US, Fujimoto Japan, Skin2Neuron Pty Ltd, Sydney, Australia, US, Special advisor to the Centre for Innovation in Regulatory Science (CIRS), London UK. From 2001 until2011, Mr.Lönngren served as the Executive Director of the European Medical Agency. He was previously Deputy General Director of the Swedish Medical Product Agency until 2000. He has a degree in pharmacy and MSc in Social and Regulatory Pharmacy from Uppsala University. He is also an Honorary Member of the Royal Pharmaceutical Society of Great Britain, Honorary Fellow of the Royal College of Physicians in Great Britain, Honorary Doctorate from the University of Uppsala, Honorary Doctorate from University of Bath, UK.

Speaker Biographies

Marie-Anne Aymerich

Marie-Anne has built a portfolio of senior advisory and non-executive roles, following a successful international career in the FMCG and Luxury sectors. She is a non-executive director of Haleon, a FTSE100 company listed in 2022 after the demerger from GSK. She is also chairwoman of Haleon Environment and Societal Sustainability committee. She is the executive director of the Pierre Fabre Group where she also sits on the Strategic Committee, and she is a Board Member of The Academy of St. Martin-in-the-Fields, one of the world’s most prestigious chamber orchestras. She is also an angel investor and focuses her time and investments on start-ups with the strongest purpose and impact.

Marie-Anne is also a regular lecturer at HEC Paris on purposeful leadership, and she has created a serious game called “Planet Purpose” to upskill people on sustainability and purpose. Throughout her 35year executive career she delivered a strong track-record of business performance and growth in brands and portfolio in both developed and emerging economies.

As a senior leader with Unilever, she led a number of different personal care categories across France, Spain and the USA – including managing the Dove brand worldwide and culminating in leading Unilever’s global Oral Care division. She also worked for LVMH as Brand General Manager of Dior Perfumes and Cosmetics worldwide. Marie-Anne was also Vice-President of Imagine for Margo – Children with Cancer for ten years, a charity she helped found in 2011 with the goal of eradicating children’s cancer. The charity is the #1 charity focused on child cancer in France and has fundraised more than €14m since its creation. Marie-Anne is a graduate from HEC Paris. She is married and has two children aged 29 and 26.

Patrick Jephson

Patrick Jephson is a consultant, journalist, broadcaster and New York Times bestselling author, based in Washington D.C. He is a published authority on corporate and personal branding and crisis communications, addressing conferences worldwide as well as events at the U.S. State Department, the American University and the Annenberg School for Communication and Journalism.

With more than twenty-five years’ experience in the government, luxury and family office sectors, Patrick’s portfolio has included globally admired brands as well as national agencies and NGOs. He has also worked on reputation and legacy briefs with European, Middle Eastern and Asian families, including royalty. He now writes, presents, and advises on factual and drama TV programs, appearing on every major American and many international networks. He was recently an expert consultant to the award-winning Netflix series The Crown and provided live commentary on the Coronation of King Charles.

Patrick owes much of his practical communications and protocol experience to Princess Diana, who chose him to be her equerry and only private secretary/chief of staff. He served the Princess for eight years, responsible for all aspects of her public life, global humanitarian initiatives, and private organization. Having worked for an internationally high-profile woman (and as the father of two professionally successful daughters) he feels a special affinity for cross-cultural, gender and perception issues.

Patrick was born and raised in Ireland and holds a master’s degree in political science from Cambridge University. As an officer in the British Royal Navy, he served all over the world before being selected for royal duty. He is a citizen of the U.K., U.S.A., Ireland, and Canada.